Start here if you're new
what it is
ATI makes specialty metals and components that end up in jet engines, airframes, defense systems, and other high-stress hardware.
how it gets paid
Last year Ati made $4.6B in revenue.
why it's growing
Revenue grew 5.2% last year. Long-term agreements, which call for the growing usage of increasingly differentiated offerings, should help maintain sales momentum into 2027.
what just happened
ATI beat estimates with $0.93 EPS, and the real story was that aerospace demand kept carrying the load.
At a glance
B+ balance sheet — decent shape, but not bulletproof
20/100 earnings predictability — expect surprises
34.5x trailing p/e — you're paying up for this one
13.5% return on capital — nothing to write home about
xvary composite: 62/100 — average
What they do
ATI makes specialty metals and components that end up in jet engines, airframes, defense systems, and other high-stress hardware.
ATI sells the materials your aircraft engine cannot fake: titanium alloys and other specialty metals. In the September period, aerospace and defense made up 70% of sales and grew 21%, which tells you customers are buying performance, not cheap metal. That shows up in a 19.5% operating margin (operating margin → profit after running the business → ATI keeps about 20 cents of every sales dollar before interest and taxes).
How they make money
$4.6B
annual revenue · their business grew +5.2% last year
total revenue
$4.6B
+5.2%
The products that matter
aerospace and defense materials
Aerospace & Defense
$792.7M in the september period · 70% of top line
this is the center of gravity. when one end market drives 70% of sales, that market becomes your thesis whether you planned it or not.
70% of sales
jet engine materials
Jet Engine Materials
2025 revenue expected to rise more than 20%
management pointed to jet engine revenue growing more than 20% in 2025. that is the growth pocket investors are paying up for.
fastest growth
missile and propulsion materials
Defense Programs
sits inside the $792.7M aerospace-and-defense bucket
demand in missile and propulsion programs is firming. if that turns into sustained orders, it helps keep the 70% aerospace-and-defense mix intact.
defense support
Key numbers
34.5x
trailing p/e
P/E → price-to-earnings → how much you pay for each dollar of profit. At 34.5x, you are paying up for growth that still needs to show up.
19.5%
operating margin
Operating margin → profit from the actual business → the factory and product mix are finally doing the heavy lifting.
13.5%
return on capital
Return on capital → profit earned on the money invested in the business → ATI is producing decent returns, but not luxury-brand returns.
42%
international sales
Nearly half of revenue comes from outside the U.S., which helps diversification but also adds trade and supply-chain exposure.
Financial health
B+
strength
- balance sheet grade B+ — solid but not elite
- risk rank 3 — safer than 50% of stocks
- price stability 30 / 100
- long-term debt $1.7B (10% of capital)
- net profit margin 12.2% — keeps 12 cents of every dollar in revenue
- return on equity 17% — $0.17 profit for every $1 investors have put in
B+ — functional but not a standout on the balance sheet.
Total return vs. market
You invested $10,000 in ATI 3 years ago → it's now worth $37,340.
The index would have given you $13,920.
source: institutional data · total return
What just happened
beat estimates
ATI beat estimates with $0.93 EPS, and the real story was that aerospace demand kept carrying the load.
Yahoo Finance shows ATI earned $0.93 versus a $0.84 estimate, a 10.71% beat. Company-reported Q4 2025 revenue was about $1.18B, which aligns with consensus data and conflicts with an EDGAR feed showing $3.4B revenue and $2.16 EPS.
$1.2B
revenue
$0.93
eps
21.5%
gross margin
10.71% beat
Beating estimates by 10.71% matters because this stock trades on execution, and ATI keeps handing the market proof.
-
ati inc. is benefiting from certain favorable trends.the maker of specialty materials noted continued vigor in core markets, especially aerospace and defense (a&d).
-
in fact, a&d sales rose 21% in the september period, to $792.7 million, and accounted for 70% of the top line.aerospace manufacturers are accelerating production rates for next-generation platforms, prompting orders for ati’s alloys and turbine materials.
-
jet engine revenue rise more than 20% in 2025, while the airframes business will likely grow at a more modest pace.long-term agreements, which call for the growing usage of increasingly differentiated offerings, should help maintain sales momentum into 2027.
-
as for the defense category, demand for the company’s products in missile and propulsion programs is firming.
-
next is strong productivity improvement amid a backdrop of expanding manufacturing capabilities.
source: company earnings report, Feb. 2026; consensus verified by Yahoo Finance
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
the top threat is the suspension of ati government solutions from new federal contract awards, but that is not the only risk on the page. You also need aerospace demand and the valuation multiple to stay cooperative.
med
federal contract suspension
the small business administration suspended ATI Government Solutions from securing new federal contracts. For a company tied to defense programs, that is not a side issue.
estimated revenue exposure: $690M–$1.1B tied to the suspended business
med
aerospace and defense concentration
70% of september-period sales came from aerospace and defense. That concentration is great when build rates rise and painful when they slow.
70% of quarterly revenue is riding on one end-market bucket
med
premium multiple, low predictability
the stock trades at 34.5x trailing earnings while earnings predictability sits at 20/100. You are paying up for a business that can still produce uneven quarters.
multiple compression becomes a real risk if EPS slips below the $3.85 expectation
med
rally fatigue
ATI is up 186% from its 52-week low, and price stability is only 30/100. Big reratings are great until the next quarter gives traders a reason to de-rate it.
the stock has less valuation cushion now than it did at $38
one contract issue threatens $690M–$1.1B in revenue, and 70% of quarterly sales already depend on aerospace and defense demand staying strong.
source: institutional data · regulatory filings · risk analysis
Pay attention to
metric
aerospace and defense mix staying near 70%
if that share starts slipping, the whole rerating story changes because 70% of the september-period top line came from that bucket.
risk
scope of the federal contract suspension
the key question is whether the issue stays contained to ATI Government Solutions or starts affecting confidence in defense-related growth.
earnings
next quarter versus the $1.1B and $0.78 baseline
you want to see revenue hold around the recent $1.1B level and EPS avoid a step back after full-year EPS reached $3.15.
trend
whether institutions stop selling into strength
the stock is near $111 highs, but institutions have been net sellers for two straight quarters. You want the ownership trend to stop arguing with the price chart.
Analyst rankings
short-term outlook
top 20%
momentum score 2 — in human-speak, analysts think ATI has above-average odds of outperforming over the next year
risk profile
average
stability score 3 — this sits in the middle of the risk pack, not in the bunker and not in the danger zone
chart momentum
average
technical score 3 — the chart is no longer giving you a fresh signal after the big run
earnings predictability
20 / 100
results are harder to model than the stock's premium multiple suggests. If you own it, expect some quarter-to-quarter noise
source: institutional data
Institutional activity
institutions have been net selling for 2 consecutive quarters — 234 buyers vs. 234 sellers in 3q2025. total institutional holdings: 0.1B shares. net selling for 2 quarters.
source: institutional data
Price targets
3-5 year target range
$69
$181
$109
current price
$125
target midpoint · +15% from current · 3-5yr high: $115 (+5% · 2% ann'l return)
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive